For information on our completed joint work projects, please call us on 01304 616161. We also have a framework agreement with the Ministry of Health. Sets out detailed working arrangements in support of a Memorandum of Understanding, including what they can expect from each other, how the work is managed, and the obligations of consultation and involvement of others in the work. We don`t have a common working protocol with every organization we work with – a moU is often enough. This should foster closer and more effective cooperation between regulatory authorities. Memorandum of Understanding between CQC, GMC and NHS England: General Practice Ahead. All joint work projects must be supported by a formal joint working agreement1, the summary of which must be made public before the start of the project. Agreements should be made at company/organisational level and not with individual healthcare professionals. Agreements must include an exit strategy, contingency arrangements, clear milestones and the obligation to measure, maintain and document results to facilitate replication and scale across the NHS. * Monitor/NHS Trust Development Authority: NHS Improvement was established on 1 April 2016 and brings together Monitor and the NHS Trust Development Authority. MoUs with these organizations still exist and are under review.
Other governance guidelines are also included in the ABPI Code of Practice and can be discussed interactively on the Prescription Medicines Code of Practice Authority (PMCPA) website 3. Each party must make an essential and defined contribution to the project and the transfers of value from companies must be made public. The contribution of resources can be in different forms, including people, expertise, equipment, communication channels, information technology and finance. In order to ensure that the joint work projects we have implemented are carried out at the highest level, we adhere to the Department of Health`s Principles of Good Practice and the Association of the British Pharmaceutical Industry (ABPI) Code of Conduct. Other examples are available as executive summaries on the ABPI Disclosure UK2 website. You can also read case studies on joint work in Appendix 1 of this document and on the websites of ABPI members. Specifies what information is shared, how, when, and with whom. ISAs are created when we need to share sensitive data with other organizations and describe in detail all the necessary security requirements. Joint work is defined as a situation in which the NHS and pharmaceutical companies collaborate, for the benefit of patients, with a shared commitment to successful administration. Joint work projects aim to achieve `triple benefits` in the form of benefits for patients, the NHS and the pharmaceutical operator(s) involved. The expected benefits must be clearly stated in advance.
Both the NHS organisation and the participating company may consider quantifying the expected benefits as an anticipated return on investment (ROI) before embarking on a joint work project. 1 www.pmcpa.org.uk/thecode/InteractiveCode2016/Pages/Clause20.aspx Download pdf “Working together – a tool for industry and the NHS” A statement of intent between two organisations to work together and sketch out what it is….